References
Ikeda Y, Dick KA, Weatherspoon MR, Gincel D, Armbrust KR, Dalton JC, et al. Spectrin mutations cause spinocerebellar ataxia type 5. Nat Genet. 2006;38(2):184–90.
Cho E, Fogel BL. A family with spinocerebellar ataxia type 5 found to have a novel missense mutation within a SPTBN2 spectrin repeat. Cerebellum. 2013;12(2):162–4.
Jacob FD, Ho ES, Martinez-Ojeda M, Darras BT, Khwaja OS. Case of infantile onset spinocerebellar ataxia type 5. J Child Neurol. 2013;28(10):1292–5.
Rea G, Tirupathi S, Williams J, Clouston P, Morrison PJ. Infantile onset of spinocerebellar ataxia type 5 (SCA-5) in a 6 month old with ataxic cerebral palsy. Cerebellum. 2020;19(1):161–3.
Parolin Schnekenberg R, Perkins EM, Miller JW, Davies WI, D’Adamo MC, Pessia M, et al. De novo point mutations in patients diagnosed with ataxic cerebral palsy. Brain. 2015;138(Pt 7):1817–32.
Nuovo S, Micalizzi A, D’Arrigo S, Ginevrino M, Biagini T, Mazza T, et al. Between SCA5 and SCAR14: delineation of the SPTBN2 p.R480W-associated phenotype. Eur J Hum Genet. 2018;26(7):928–9.
Nicita F, Nardella M, Bellacchio E, Alfieri P, Terrone G, Piccini G, et al. Heterozygous missense variants of SPTBN2 are a frequent cause of congenital cerebellar ataxia. Clin Genet. 2019;96(2):169–75.
Mizuno T, Kashimada A, Nomura T, Moriyama K, Yokoyama H, Hasegawa S, et al. Infantile-onset spinocerebellar ataxia type 5 associated with a novel SPTBN2 mutation: a case report. Brain and Development. 2019;41(7):630–3.
Accogli A, St-Onge J, Addour-Boudrahem N, Lafond-Lapalme J, Laporte AD, Rouleau GA, et al. Heterozygous missense pathogenic variants within the second spectrin repeat of SPTBN2 lead to infantile-onset cerebellar ataxia. J Child Neurol. 2020;35(2):106–10.
Dick KA, Ikeda Y, Day JW, Ranum LP. Spinocerebellar ataxia type 5. Handb Clin Neurol. 2012;103:451–9.
Perkins E, Suminaite D, Jackson M. Cerebellar ataxias: β-III spectrin’s interactions suggest common pathogenic pathways. J Physiol. 2016;594(16):4661–76.
Lorenzo DN, Li MG, Mische SE, Armbrust KR, Ranum LP, Hays TS. Spectrin mutations that cause spinocerebellar ataxia type 5 impair axonal transpor t and induce neurodegeneration in Drosophila. J Cell Biol. 2010;189:143–58.
Rossor AM, Carr AS, Devine H, Chandrashekar H, Pelayo-Negro AL, Pareyson D, et al. Peripheral neuropathy in complex inherited diseases: an approach to diagnosis. J Neurol Neurosurg Psychiatry. 2017;88(10):846–63.
Martin PB, Hicks AN, Holbrook SE, Cox GA. Overlapping spectrums: the clinicogenetic commonalities between Charcot-Marie-Tooth and other neurodegenerative diseases. Brain Res. 2020;1727:146532.
Batla A, Tai XY, Schottlaender L, Erro R, Balint B, Bhatia KP. Deconstructing Fahr’s disease/syndrome of brain calcification in the era of new genes. Parkinsonism Relat Disord. 2017;37:1–10.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Spagnoli, C., Frattini, D., Gozzi, F. et al. Infantile-Onset Spinocerebellar Ataxia Type 5 (SCA5) with Optic Atrophy and Peripheral Neuropathy. Cerebellum 20, 481–483 (2021). https://doi.org/10.1007/s12311-020-01214-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12311-020-01214-7